Facing hospital closures, underfunded pediatric trials, and a persistent reliance on adult-oriented tools for children, the Hood Pediatric Innovation Hub welcomed nearly 200 leaders at Boston’s Museum of Science for MIT-Hood Pediatric Innovation 2025, an event focused on transforming the future of pediatric care through engineering and collaboration.

Hosted by the Hood Pediatric Innovation Hub — established at MIT through a gift by the Hood Foundation — the event brought together attendees from academia, health care, and industry to rethink how medical and technological breakthroughs can reach children faster. The gathering marked a new phase in the hub’s mission to connect scientific discovery with real-world impact.

“We have extraordinary science emerging every day, but the translation gap is widening,” said Joseph Frassica, professor of the practice in MIT’s Institute for Medical Engineering and Science and executive director of the Hood Pediatric Innovation Hub. “We can’t rely on the old model of innovation — we need new connective tissue between ideas, institutions, and implementation.”

Building collaboration across sectors

Speakers emphasized that pediatric medicine has long faced structural disadvantages compared with other fields — from smaller patient populations to limited commercial incentives. Yet they also described a powerful opportunity: to make pediatric innovation a proving ground for smarter, more human-centered health systems.

“The Hood Foundation has always believed that if you can improve care for children, you improve care for everyone,” said Neil Smiley, president of the Charles H. Hood Foundation. “Pediatrics pushes medicine to be smarter, more precise, and more humane — and that’s why this collaboration with MIT feels so right.”

Participants discussed how aligning efforts across universities, hospitals, and industry partners could help overcome the fragmentation that slows innovation, and ultimately translation. Speakers at the event highlighted case studies where cross-sector collaboration is already yielding results — from novel medical devices to data-driven clinical insights.

Connecting discovery to delivery

In his remarks, Elazer R. Edelman, the Edward J. Poitras Professor in Medical Engineering and Science at MIT and faculty lead for the Hood Pediatric Innovation Hub, reflected on how MIT’s engineering and medical communities can help close the loop between research and clinical application.

“This isn’t about creating something new for the sake of it — it’s about finally connecting the extraordinary expertise that already exists, from the lab to the clinic to the child’s bedside,” Edelman said. “That’s what MIT does best — we connect the dots.”

Throughout the day, attendees shared experiences from both the engineering and clinical viewpoints — acknowledging the complexities of regulation, funding, and adoption, while highlighting the shared responsibility to move faster on behalf of children.

A moment of convergence

The conversation also turned to the economics of innovation and the broader societal benefits of investing in pediatric health.

“The economic and social stakes couldn’t be higher,” said Jonathan Gruber, Ford Professor of Economics at MIT. “When we invest in children’s health, we invest in longer lives, stronger communities, and greater prosperity. The energy in this room shows what’s possible when we stop working in silos.”

By the end of the event, discussions had shifted from identifying barriers to designing solutions. Participants explored ideas ranging from translational fellowships and shared data platforms to new models for academic–industry partnership — each aimed at accelerating impact where it is needed most.

Looking ahead

“There’s a feeling that this is the moment,” Frassica said. “We have the tools, the data, and the will to transform how we care for children. The key now is keeping that spirit of collaboration alive — because when we do, we move the whole field forward.”

Building on the momentum from MIT-Hood Pediatric Innovation 2025, the Hood Pediatric Innovation Hub will continue to serve as a connector across disciplines and institutions, advancing projects that translate cutting-edge research into improved outcomes for children everywhere. In January, a new cohort of MIT Catalyst Fellows — early-career researchers embedded with frontline clinicians to identify unmet needs — will begin exploring solutions to challenges in pediatric and neonatal health care in partnership with the hub. 

This work is also part of a wider Institute effort. The Hood Pediatric Innovation Hub contributes to the broader mission of the MIT Health and Life Sciences Collaborative (HEALS), which brings together faculty, clinicians, and industry partners to accelerate breakthroughs across all areas of human health. As the hub deepens its own collaborations, its connection to HEALS helps ensure that advances in pediatric medicine are integrated into MIT’s larger push to improve health outcomes at scale.

The hub will also release a request for proposals in the coming months for the development of its first mentored projects — designed to bring together teams from engineering, medicine, and industry to accelerate progress in children’s health. Updates and details will be available at hoodhub.mit.edu.

As Smiley noted, progress in pediatric health often drives progress across all of medicine — and this gathering underscored that shared belief: when we work together for children, we build a healthier future for everyone.

As people age, their immune system function declines. T cell populations become smaller and can’t react to pathogens as quickly, making people more susceptible to a variety of infections.

To try to overcome that decline, researchers at MIT and the Broad Institute have found a way to temporarily program cells in the liver to improve T-cell function. This reprogramming can compensate for the age-related decline of the thymus, where T cell maturation normally occurs.

Using mRNA to deliver three key factors that usually promote T-cell survival, the researchers were able to rejuvenate the immune systems of mice. Aged mice that received the treatment showed much larger and more diverse T cell populations in response to vaccination, and they also responded better to cancer immunotherapy treatments.

If developed for use in patients, this type of treatment could help people lead healthier lives as they age, the researchers say.

“If we can restore something essential like the immune system, hopefully we can help people stay free of disease for a longer span of their life,” says Feng Zhang, the James and Patricia Poitras Professor of Neuroscience at MIT, who has joint appointments in the departments of Brain and Cognitive Sciences and Biological Engineering.

Zhang, who is also an investigator at the McGovern Institute for Brain Research at MIT, a core institute member at the Broad Institute of MIT and Harvard, an investigator in the Howard Hughes Medical Institute, and co-director of the K. Lisa Yang and Hock E. Tan Center for Molecular Therapeutics at MIT, is the senior author of the new study. Former MIT postdoc Mirco Friedrich is the lead author of the paper, which appears today in Nature.

A temporary factory

The thymus, a small organ located in front of the heart, plays a critical role in T-cell development. Within the thymus, immature T cells go through a checkpoint process that ensures a diverse repertoire of T cells. The thymus also secretes cytokines and growth factors that help T cells to survive.

However, starting in early adulthood, the thymus begins to shrink. This process, known as thymic involution, leads to a decline in the production of new T cells. By the age of approximately 75, the thymus is greatly reduced.

“As we get older, the immune system begins to decline. We wanted to think about how can we maintain this kind of immune protection for a longer period of time, and that's what led us to think about what we can do to boost immunity,” Friedrich says.

Previous work on rejuvenating the immune system has focused on delivering T cell growth factors into the bloodstream, but that can have harmful side effects. Researchers are also exploring the possibility of using transplanted stem cells to help regrow functional tissue in the thymus.

The MIT team took a different approach: They wanted to see if they could create a temporary “factory” in the body that would generate the T-cell-stimulating signals that are normally produced by the thymus.

“Our approach is more of a synthetic approach,” Zhang says. “We're engineering the body to mimic thymic factor secretion.”

For their factory location, they settled on the liver, for several reasons. First, the liver has a high capacity for producing proteins, even in old age. Also, it’s easier to deliver mRNA to the liver than to most other organs of the body. The liver was also an appealing target because all of the body’s circulating blood has to flow through it, including T cells.

To create their factory, the researchers identified three immune cues that are important for T-cell maturation. They encoded these three factors into mRNA sequences that could be delivered by lipid nanoparticles. When injected into the bloodstream, these particles accumulate in the liver and the mRNA is taken up by hepatocytes, which begin to manufacture the proteins encoded by the mRNA.

The factors that the researchers delivered are DLL1, FLT-3, and IL-7, which help immature progenitor T cells mature into fully differentiated T cells.

Immune rejuvenation

Tests in mice revealed a variety of beneficial effects. First, the researchers injected the mRNA particles into 18-month-old mice, equivalent to humans in their 50s. Because mRNA is short-lived, the researchers gave the mice multiple injections over four weeks to maintain a steady production by the liver.

After this treatment, T cell populations showed significant increases in size and function.

The researchers then tested whether the treatment could enhance the animals’ response to vaccination. They vaccinated the mice with ovalbumin, a protein found in egg whites that is commonly used to study how the immune system responds to a specific antigen. In 18-month-old mice that received the mRNA treatment before vaccination, the researchers found that the population of cytotoxic T-cells specific to ovalbumin doubled, compared to mice of the same age that did not receive the mRNA treatment.

The mRNA treatment can also boost the immune system’s response to cancer immunotherapy, the researchers found. They delivered the mRNA treatment to 18-month-old mice, who were then implanted with tumors and treated with a checkpoint inhibitor drug. This drug, which targets the protein PD-L1, is designed to help take the brakes off the immune system and stimulate T cells to attack tumor cells.

Mice that received the treatment showed much higher survival rates and longer lifespan that those that received the checkpoint inhibitor drug but not the mRNA treatment.

The researchers found that all three factors were necessary to induce this immune enhancement; none could achieve all aspects of it on their own. They now plan to study the treatment in other animal models and to identify additional signaling factors that may further enhance immune system function. They also hope to study how the treatment affects other immune cells, including B cells.

Other authors of the paper include Julie Pham, Jiakun Tian, Hongyu Chen, Jiahao Huang, Niklas Kehl, Sophia Liu, Blake Lash, Fei Chen, Xiao Wang, and Rhiannon Macrae.

The research was funded, in part, by the Howard Hughes Medical Institute, the K. Lisa Yang Brain-Body Center, part of the Yang Tan Collective at MIT, Broad Institute Programmable Therapeutics Gift Donors, the Pershing Square Foundation, J. and P. Poitras, and an EMBO Postdoctoral Fellowship.

For two days in September, Afghanistan had no internet. No satellite failed; no cable was cut. This was a deliberate outage, mandated by the Taliban government. It followed a more localized shutdown two weeks prior, reportedly instituted “to prevent immoral activities.” No additional explanation was given. The timing couldn’t have been worse: communities still reeling from a major earthquake lost emergency communications, flights were grounded, and banking was interrupted. Afghanistan’s blackout is part of a wider pattern. Just since the end of September, there were also major nationwide internet shutdowns in ...

The president’s swift destruction of regulations in his first year could help him make lasting changes, with the Supreme Court’s help.

The department used its emergency powers to delay the plant's retirement, which is a staple of the state's climate plans.

Property insurance price hikes and claims denials emerge as a political issue. "Being overcharged and cheated ... is a nonpartisan sentiment," Republican Gentner Drummond said.

The results suggest that public perceptions of the data center boom are still politically malleable.

A final energy plan approved by policymakers won’t meet the state's landmark 2019 climate law goals.

Under the latest deal, automakers could sell plug-in hybrids and range extenders after 2035.

Stricter climate policies would save hundreds of glaciers in Europe’s Alps and tens of thousands worldwide, study finds.

Assisted fertilization is gaining momentum in the Caribbean to counter the drastic loss of corals due to climate change.

A study used by the Network for Greening the Financial System that projected severe economic fallout from climate change was retracted.

This article may be updated.

Nuno Loureiro, a professor of nuclear science and engineering and of physics at MIT, has died. He was 47.

A lauded theoretical physicist and fusion scientist, and director of the MIT Plasma Science and Fusion Center, Loureiro joined MIT’s faculty in 2016. His research addressed complex problems lurking at the center of fusion vacuum chambers and at the edges of the universe.

Loureiro’s research at MIT advanced scientists’ understanding of plasma behavior, including turbulence, and uncovered the physics behind astronomical phenomena like solar flares. He was the Herman Feshbach (1942) Professor of Physics at MIT and was named director of the Plasma Science and Fusion Center in 2024, though his contributions to fusion science and engineering began far before that.

His research on magnetized plasma dynamics, magnetic field amplification, and confinement and transport in fusion plasmas helped inform the design of fusion devices that could harness the energy of fusing plasmas, bringing the dream of clean, near-limitless fusion power closer to reality.

“Nuno was not only a brilliant scientist, he was a brilliant person,” says Dennis Whyte, the Hitachi America Professor of Engineering, who previously served as the head of the Department of Nuclear Science and Engineering and director of the Plasma Science and Fusion Center. “He shone a bright light as a mentor, friend, teacher, colleague and leader, and was universally admired for his articulate, compassionate manner. His loss is immeasurable to our community at the PSFC, NSE and MIT, and around the entire fusion and plasma research world.”

“Nuno was a champion for plasma physics within the Physics Department, a wonderful and engaging colleague, and an inspiring and caring mentor for graduate students working in plasma science.  His recent work on quantum computing algorithms for plasma physics simulations was a particularly exciting new scientific direction,” says Deepto Chakrabarty, the William A. M. Burden Professor in Astrophysics and head of the Department of Physics.

Whether working on fusion or astrophysics research, Loureiro merged fundamental physics with technology and engineering, to maximize impact.

“There are people who are driven by technology and engineering, and others who are driven by fundamental mathematics and physics. We need both,” Loureiro said in 2019. “When we stimulate theoretically inclined minds by framing plasma physics and fusion challenges as beautiful theoretical physics problems, we bring into the game incredibly brilliant students — people who we want to attract to fusion development.”

Loureiro majored in physics at Instituto Superior Tecnico (IST) in Portugal and obtained a PhD in physics at Imperial College London in 2005. He conducted postdoctoral work at the Princeton Plasma Physics Laboratory for the next two years before moving to the UKAEA Culham Center for Fusion Energy in 2007. Loureiro returned to IST in 2009, where he was a researcher at the Institute for Plasmas and Nuclear Fusion until coming to MIT in 2016.

He wasted no time contributing to the intellectual environment at MIT, spending part of his first two years at the Institute working on the vexing problem of plasma turbulence. Plasma is the super-hot state of matter that serves as the fuel for fusion reactors. Loureiro’s lab at PSFC illuminated how plasma behaves inside fusion reactors, which could help prevent material failures and better contain the plasma to harvest electricity.

“Nuno was not only an extraordinary scientist and educator, but also a tremendous colleague, mentor, and friend who cared deeply about his students and his community. His absence will be felt profoundly across NSE and far beyond,” Benoit Forget, the KEPCO Professor and head of the Department of Nuclear Science and Engineering, wrote in an email to the department today.

On other fronts, Loureiro’s work in astrophysics helped reveal fundamental mechanisms of the universe. He put forward the first theory of turbulence in pair plasmas, which differ from regular plasmas and may be abundant in space. The work was driven, in part, by unprecedented observations of a binary neutron star merger in 2018.

As an assistant professor and then a full professor at MIT, Loureiro taught course 22.612 (Intro to Plasma Physics) and course 22.615 (MHD Theory of Fusion Systems), for which he was twice recognized with the Department of Nuclear Science and Engineering’s PAI Outstanding Professor Award.

Loureiro’s research earned him many prominent awards throughout his prolific career, including the National Science Foundation Career Award and the American Physical Society Thomas H. Stix Award for Outstanding Early Career Contributions to Plasma Physics Research. He was also an APS fellow. Earlier this year, he earned the Presidential Early Career Award for Scientists and Engineers.

The world’s most common construction material has a secret. Cement, the “glue” that holds concrete together, gradually “breathes in” and stores millions of tons of carbon dioxide (CO2) from the air over the lifetimes of buildings and infrastructure.  

A new study from the MIT Concrete Sustainability Hub quantifies this process, carbon uptake, at a national scale for the first time. Using a novel approach, the research team found that the cement in U.S. buildings and infrastructure sequesters over 6.5 million metric tons of CO2 annually. This corresponds to roughly 13 percent of the process emissions — the CO2 released by the underlying chemical reaction — in U.S. cement manufacturing. In Mexico, the same building stock sequesters about 5 million tons a year.   

But how did the team come up with those numbers? 

Scientists have known how carbon uptake works for decades. CO2 enters concrete or mortar — the mixture that glues together blocks, brick, and stones — through tiny pores, reacts with the calcium-rich products in cement, and becomes locked into a stable mineral called calcium carbonate, or limestone. 

The chemistry is well-known, but calculating the magnitude of this at scale is not. A concrete highway in Dallas sequesters CO2 differently than Mexico City apartments made from concrete masonry units (CMUs), also called concrete blocks or, colloquially, cinder blocks. And a foundation slab buried under the snow in Fairbanks, Alaska, “breathes in” CO2 at a different pace entirely. 

As Hessam AzariJafari, lead author and research scientist in the MIT Department of Civil and Environmental Engineering, explains, “Carbon uptake is very sensitive to context. Four major factors drive it: the type of cement used, the product we make with it — concrete, CMUs, or mortar — the geometry of the structure, and the climate and conditions it’s exposed to. Even within the same structure, uptake can vary five-fold between different elements.” 

As no two structures sequester CO2 in the same way, estimating uptake nationwide would normally require simulating an array of cement-based elements: slabs, walls, beams, columns, pavements, and more. On top of that, each of those has its own age, geometry, mixture, and exposure condition to account for.  

Seeing that this approach would be like trying to count every grain of sand on a beach, the team took a different route. They developed hundreds of archetypes, typical designs that could stand in for different buildings and pieces of infrastructure. It’s a bit like measuring the beach instead by mapping out its shape, depth, and shoreline to estimate how much sand usually sits in a given spot.  

With these archetypes in hand, the team modeled how each one sequesters CO2 in different environments and how common each is across every state in the United States and Mexico. In this way, they could estimate not just how much CO2 structures sequester, but why those numbers differ.  

Two factors stood out. The first was the “construction trend,” or how the amount of new construction had changed over the previous five years. Because it reflects how quickly cement products are being added to the building stock, it shapes how much cement each state consumes and, therefore, how much of that cement is actively carbonating. The second was the ratio of mortar to concrete, since porous mortars sequester CO2 an order of magnitude faster than denser concrete. 

In states where mortar use was higher, the fraction of CO2 uptake relative to process emissions was noticeably greater. “We observed something unique about Mexico: Despite using half the cement that the U.S. does, the country has three-quarters of the uptake,” notes AzariJafari. “This is because Mexico makes more use of mortars and lower-strength concrete, and bagged cement mixed on-site. These practices are why their uptake sequesters about a quarter of their cement manufacturing emissions.” 

While care must be taken for structural elements that use steel reinforcement, as uptake can accelerate corrosion, it’s possible to enhance the uptake of many elements without negative impacts. 

Randolph Kirchain, director of the MIT Concrete Sustainability Hub, principal research scientist in the MIT Materials Research Laboratory, and the senior author of this study, explains: “For instance, increasing the amount of surface area exposed to air accelerates uptake and can be achieved by foregoing painting or tiling, or choosing designs like waffle slabs with a higher surface area-to-volume ratio. Additionally, avoiding unnecessarily stronger, less-porous concrete mixtures than required would speed up uptake while using less cement.” 

“There is a real opportunity to refine how carbon uptake from cement is represented in national inventories,” AzariJafari comments. “The buildings around us and the concrete beneath our feet are constantly ‘breathing in’ millions of tons of CO2. Nevertheless, some of the simplified values in widely used reporting frameworks can lead to higher estimates than what we observe empirically. Integrating updated science into international inventories and guidelines such as the Intergovernmental Panel on Climate Change (IPCC) would help ensure that reported numbers reflect the material and temporal realities of the sector.” 

By offering the first rigorous, bottom-up estimation of carbon uptake at a national scale, the team’s work provides a more representative picture of cement’s environmental impact. As we work to decarbonize the built environment, understanding what our structures are already doing in the background may be just as important as the innovations we pursue moving forward. The approach developed by MIT researchers could be extended to other countries by combining global building-stock databases with national cement-production statistics. It could also inform the design of structures that safely maximize uptake. 

The findings were published Dec. 15 in the  Proceedings of the National Academy of Sciences. Joining AzariJafari and Kirchain on the paper are MIT researchers Elizabeth Moore of the Department of Materials Science and Engineering and the MIT Climate Project and former postdocs Ipek Bensu Manav SM ’21, PhD ’24 and Motahareh Rahimi, along with Bruno Huet and Christophe Levy from the Holcim Innovation Center in France.

The final EFFector of 2025 is here! Just in time to keep you up-to-date on the latests happenings in the fight for privacy and free speech online.

In this latest issue, we're sharing how to spot sneaky ALPR cameras at the U.S. border, covering a host of new resources on age verification laws, and explaining why AI companies need to protect chatbot logs from bulk surveillance.

Prefer to listen in? Check out our audio companion, where EFF Activist Molly Buckley explains our new resource explaining age verification laws and how you can fight back. Catch the conversation on YouTube or the Internet Archive.

LISTEN TO EFFECTOR

EFFECTOR 37.18 - 🪪 AGE VERIFICATION IS COMING FOR THE INTERNET

Since 1990 EFF has published EFFector to help keep readers on the bleeding edge of their digital rights. We know that the intersection of technology, civil liberties, human rights, and the law can be complicated, so EFFector is a great way to stay on top of things. The newsletter is chock full of links to updates, announcements, blog posts, and other stories to help keep readers—and listeners—up to date on the movement to protect online privacy and free expression. 

Thank you to the supporters around the world who make our work possible! If you're not a member yet, join EFF today to help us fight for a brighter digital future.

New report: “The Party’s AI: How China’s New AI Systems are Reshaping Human Rights.” From a summary article:

China is already the world’s largest exporter of AI powered surveillance technology; new surveillance technologies and platforms developed in China are also not likely to simply stay there. By exposing the full scope of China’s AI driven control apparatus, this report presents clear, evidence based insights for policymakers, civil society, the media and technology companies seeking to counter the rise of AI enabled repression and human rights violations, and China’s growing efforts to project that repression beyond its borders...

The House-passed National Defense Authorization Act would spur an investigation of whether the U.S. military bio-engineered Lyme disease.

Withdrawals are increasing as the government hikes its premiums to in part compensate for damage associated with climate change.

The price of crude has dropped since the president ordered the capture of a sanctioned tanker carrying 2 million barrels of Venezuelan oil.

The Energy secretary said supporting the use of more fossil fuels is “common sense" as he bashed renewables.